# Cardiff Oncology, Inc.: Form DEF 14A, filed Aug 26, 2026

- Company: [Cardiff Oncology, Inc.](/companies/crdf.md) (CIK 1213037)
- Form: DEF 14A
- Filed: 2026-08-26
- Accepted by EDGAR: Aug 26, 2026, 16:01 ET
- Period: 2026-08-26
- Accession: 0001193125-26-368249
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1213037/000119312526368249/crdf_def_14a_special_pro.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1213037/000119312526368249/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1213037/000119312526368249/crdf_def_14a_special_pro.htm

Filed Aug 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-368249. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.
